Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dalgleish

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of Medical Virology|May 1, 1987
Human immunodeficiency virus (HIV) infection in the regular sexual partners of homosexual men with AIDS and persistent generalised lymphadenopathyI V Weller, C A Carne, Q Sattentau, et al.
Lancet (London, England)|September 1, 1984
Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in LondonB G Gazzard, D C Shanson, C Farthing, et al.
Clinical and Experimental Immunology|November 11, 1999
A lack of evidence for down-modulation of CD3 zeta expression in colorectal carcinoma and pregnancy using multiple detection methodsA M Deakin, K Singh, J S Crowe, et al.
British Journal of Haematology|May 1, 1996
Human T leukaemia virus type 1 (HTLV-1) specific T-helper cell response: clonal fluctuations and repertoire heterogeneityG Li Pira, M Westby, L Oppezzi, et al.
Journal of Medical Primatology|June 28, 2000
Study of immunological and virological parameters during thalidomide treatment of SIV-infected cynomolgus monkeysS Di Fabio, D Trabattoni, A Geraci, et al.
Lancet (London, England)|September 1, 1984
Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in BritainR Cheingsong-Popov, R A Weiss, A Dalgleish, et al.
AIDS (London, England)|March 28, 1998
Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeysS Di Fabio, D Trabattoni, A Geraci, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2008
An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancerP M Patel, S Sim, D O O'Donnell, et al.
Human Molecular Genetics|July 1, 2005
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutationsP J Pollard, J J Brière, N A Alam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2019
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trialP G Corrie, A Marshall, P D Nathan, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Medical Virology|May 1, 1987
Human immunodeficiency virus (HIV) infection in the regular sexual partners of homosexual men with AIDS and persistent generalised lymphadenopathyI V Weller, C A Carne, Q Sattentau, et al.
Lancet (London, England)|September 1, 1984
Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in LondonB G Gazzard, D C Shanson, C Farthing, et al.
Clinical and Experimental Immunology|November 11, 1999
A lack of evidence for down-modulation of CD3 zeta expression in colorectal carcinoma and pregnancy using multiple detection methodsA M Deakin, K Singh, J S Crowe, et al.
British Journal of Haematology|May 1, 1996
Human T leukaemia virus type 1 (HTLV-1) specific T-helper cell response: clonal fluctuations and repertoire heterogeneityG Li Pira, M Westby, L Oppezzi, et al.
Journal of Medical Primatology|June 28, 2000
Study of immunological and virological parameters during thalidomide treatment of SIV-infected cynomolgus monkeysS Di Fabio, D Trabattoni, A Geraci, et al.
Lancet (London, England)|September 1, 1984
Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in BritainR Cheingsong-Popov, R A Weiss, A Dalgleish, et al.
AIDS (London, England)|March 28, 1998
Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeysS Di Fabio, D Trabattoni, A Geraci, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2008
An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancerP M Patel, S Sim, D O O'Donnell, et al.
Human Molecular Genetics|July 1, 2005
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutationsP J Pollard, J J Brière, N A Alam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2019
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trialP G Corrie, A Marshall, P D Nathan, et al.
Pageof 6